NCT06194019

Brief Summary

Chronic kidney disease (CKD) is a major health problem worldwide.(1) Chronic renal failure is defined as a decrease in glomerular filtration rate (GFR) of less than 60 ml/min/1.73 m2 of body surface evolving for more than 3 months

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
1mo left

Started Jul 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jul 2024Jul 2026

First Submitted

Initial submission to the registry

December 21, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 8, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

January 17, 2024

Status Verified

December 1, 2023

Enrollment Period

2 years

First QC Date

December 21, 2023

Last Update Submit

January 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluation of volume status changes in children on regular hemodialysis at Assiut university children's hospital

    Evaluation of Volume status in children on regular haemodialysis by Chest sonar Evaluation of Volume status in children on regular haemodialysis by Chest sonar Evaluation of Volume status in children on regular haemodialysis by Chest sonar Evaluation of Volume status in children on regular haemodialysis by Chest sonar Evaluation of Volume status in children on regular haemodialysis by Chest sonar

    two year

Interventions

N-terminal pro-brain natriuretic peptide (NT-proBNP) as a biomarker for detection volume overload.

Also known as: Bioimpedance analysis (BIA)

Eligibility Criteria

Age3 Years - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

All cases with end stage renal diseases undergoing regular haemodialysis in nephrology department in a period of two year

You may qualify if:

  • \- Patients aged 3 to 16 years having end stage renal disease undergoing regular haemodialysis for at least more than 6 months of both gender were enrolled

You may not qualify if:

  • Patients with chronic lung disease ,or pulmonary infection in the last 2 months were excluded from study.
  • Patients with congestive heart failure Patients with Pulmonary edema Patient with pericardial effusion parental refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Ahlam Badawy, assist prof

    Assiut University

    STUDY DIRECTOR
  • Asmaa Ahmed, lecturer

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Mohamed Mahrous, prof

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

December 21, 2023

First Posted

January 8, 2024

Study Start

July 1, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

January 17, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share